PillRx only · Tablet · Oral
Lamotrigine Extended Release
Lamotrigine
0 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US3 NDCs
0 active makers
0 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers1 labelers
Packages3
DEA / ScheduleNone
US acquisition costNADAC · per unit
Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.938
Latest avg · Jun 17, 2026
-7%
Since Dec 17, 2025
0
Active US suppliers
Who makes it0 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Par Health USA, LLC | unknown | 3 | EXITED 2026 |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.